FDA places “black box” warning on antidiabetes drugs
AUTOR(ES)
Tanne, Janice Hopkins
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1892463Documentos Relacionados
- FDA urges “black box” warning on pediatric antidepressants
- FDA panel urges "black box" warning for antidepressants
- “Black box” pharmacogenetic decision-support tools in psychiatry
- Ten years after the FDA black box warning for antidepressant drugs: a critical narrative review
- Managing care, incentives, and information: an exploratory look inside the "black box" of hospital efficiency.